secwatch.observer — SEC 8-K summary
======================================

Issuer:     Galera Therapeutics, Inc. (GRTX)
CIK:        0001563577
Form:       8-K
Filed at:   2024-06-07T23:59:59+00:00
Accession:  0001193125-24-156660
Event type: leadership
Sentiment:  negative
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Galera Therapeutics eliminates COO role; stock moves to OTC Pink
----------------------------------------------------------------

- COO Robert Beardsley's position eliminated June 4, 2024 to reduce costs.
- Company continues comprehensive review of strategic alternatives.
- Beardsley eligible for severance; expects consulting at ~$400/hour.
- Common stock now quoted on OTC Pink (GRTX); Nasdaq trading suspended.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1563577/000119312524156660/0001193125-24-156660-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1563577/000119312524156660/d472894d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-156660

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer